表紙
市場調査レポート

ブドウ膜炎の予測:主要10市場

Uveitis Forecast in 10 Major Markets 2015-2025

発行 Black Swan Analysis 商品コード 339834
出版日 ページ情報 英文 46 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
ブドウ膜炎の予測:主要10市場 Uveitis Forecast in 10 Major Markets 2015-2025
出版日: 2015年08月01日 ページ情報: 英文 46 Pages
概要

当レポートでは、主要10市場 (米国、フランス、ドイツ、イタリア、スペイン、英国、ブラジル、日本、中国、インド) におけるブドウ膜炎の現在の患者数 (性別、年齢コホート別) について調査分析し、現在の有病率のほか、ASDの概要、危険因子、疾患の診断と予後、主な症状や合併症など、体系的な情報を提供しています。

図表

概要

イントロダクション

病因

危険因子と予防

疾患の診断

変異:地域/民族別

疾患予後と臨床経過

Standardisation of Uveitis Nomenclature (SUN) Working Groupのガイドライン

疾患に関連する主な合併症/症候

患者数の定量化手法

ブドウ膜炎の有病率トップライン

ブドウ膜炎:目における解剖学的部位別

ブドウ膜炎の原因論

  • 前部ブドウ膜炎
  • 中間部ブドウ膜炎
  • 後部ブドウ膜炎

ブドウ膜炎の感染原因

ブドウ膜炎の眼科感染症

参考文献

付録

目次
Product Code: UVED0010815

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Uveitis in 10 Major Markets Uveitis is a general term associated with a group of inflammatory conditions that produce swelling and causes injury to the eye. The cause of Uveitis varies greatly in respect to the geography. The main causes include that of infectious agents or linked to systemic autoimmune diseases. In this report the infectious and immune causes of Uveitis are examined. This report provides the current prevalent population for Uveitis across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, China and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors and prevention, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Uveitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Uveitis include:

  • Autoimmune diseases (systemic)
  • Ocular hypertension
  • Macular oedema
  • Reduction in visual acuity
  • Presence of epiretinal membranes
  • Diabetes mellitus
  • Tuberculosis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Uveitis's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Uveitis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Useful in the identification and trend of the prevalence numbers for the different causative agents of Uveitis.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Uveitis's prevalent population.
  • Identify sub-populations within Uveitis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Uveitis patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, CN, IN

Table of Contents

List of Tables & Figures

Overview

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Standardisation of Uveitis Nomenclature (SUN) Working Group Guidelines

Key Co-morbid Conditions Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Uveitis Prevalence

Uveitis by Anatomical Location in the Eye

Aetiology of Uveitis

  • Anterior Uveitis
  • Intermediate Uveitis
  • Posterior Uveitis

Infectious Causes of Uveitis

Co-morbid Ophthalmic Conditions for Uveitis

References

Appendix

List of Tables & Figures

  • The SUN Working Group Anatomic Classification of Uveitis (000s)
  • The SUN Working Group Descriptors of Uveitis (000s)
  • Prevalence of Uveitis, total (000s)
  • Prevalence of Uveitis, males (000s)
  • Prevalence of Uveitis, females (000s)
  • Uveitis by anatomical site, total (000s)
  • Aetiology of anterior uveitis, total (000s)
  • Duration of attack for anterior uveitis, total (000s)
  • Aetiology of intermediate uveitis, total (000s)
  • Aetiology of posterior uveitis, total (000s)
  • Aetiology of panuveitis, total (000s)
  • Infectious uveitis by casual agent, total (000s)
  • Prevalence of ocular hypertension within uveitis patients, total (000s)
  • Prevalence of macular oedema within uveitis patients, total (000s)
  • Prevalence of epiretinal membranes within uveitis patients, total (000s)
  • USA Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • USA Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • France Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • France Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • Germany Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • Italy Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • Spain Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • China Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • Japan Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • Japan Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • China Prevalence of Uveitis by 5-yr age cohort, females (000s)
  • India Prevalence of Uveitis by 5-yr age cohort, males (000s)
  • India Prevalence of Uveitis by 5-yr age cohort, females (000s)
Back to Top